AARON STOREY: Open Payments
NPI 1134672553 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,215 in 109 payments from 15 companies in 2025. Trend: 2023 $735 · 2024 $971 · 2025 $2,215
Food & beverage: $2,130Education: $85
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 24 | $582 |
| ABBVIE INC. | 28 | $468 |
| PFIZER INC. | 8 | $191 |
| Janssen Biotech, Inc. | 7 | $188 |
| UCB, Inc. | 7 | $162 |
| Regeneron Healthcare Solutions, Inc. | 7 | $149 |
| Arcutis Biotherapeutics, Inc. | 12 | $141 |
| LEO Pharma Inc. | 4 | $87 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $47 |
Products named: NEMLUVIO, SKYRIZI, TREMFYA, DUPIXENT, CIBINQO, Bimzelx, Zoryve, RINVOQ.
Industry payments across NV — which companies pay providers there.
